Tag: CD3-targeted cancer therapy

Home / CD3-targeted cancer therapy

Categories

Development and future potential of the BiTE (bispecific T-cell engager) platform

Immuno-oncology is a way to treat cancer by using the body's immune system. BiTE (bispecific T-cell engager) technology is a targeted immuno-oncology platform that binds a patient's own T cells to can...
cd3-targeted-cancer-therapy

Scan the code